Your browser does not support iframes.
N&O 100
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
(NQ:
)
N/A
UNCHANGED
Last Price
/ Updated:
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Stories about
< Previous
1
2
Next >
Watch for Continued Losses in Shares of NeurogesX (NGSX)
May 10, 2012
from
Comtex SmarTrend® News Briefs
UPDATE 1-NeurogesX seeks partners for pain drugs
April 17, 2012
April 17 (Reuters) - Pharmaceutical company NeurogesX Inc appointed advisory firm JSB-Partners to help find partners for its neuropathic pain drugs.
Read More
category
companyNews
from
Reuters: Company News
NeurogesX (NGSX) Taps Advisor in Evaluating Development Objectives
April 17, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7348843 for the full story.
Read More
from
StreetInsider.com News Articles
Hot Stock: NeurogesX, Shares Gain 27.2% (NGSX)
April 11, 2012
from
Comtex SmarTrend® News Briefs
UPDATE: Pre-Open Movers 4/11: (TZOO) (MFRM) (AA) Higher; (NOK) (OPNT) (CSC) Lower (more...)
April 11, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7337466 for the full story.
Read More
from
StreetInsider.com News Articles
NeurogesX (NGSX) Gets FDA Acceptance for End-of-Phase 2 Meeting for NGX-1998
April 11, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7336831 for the full story.
Read More
from
StreetInsider.com News Articles
NeurogesX: New 52-Week Low Set Today (NGSX)
April 10, 2012
from
Comtex SmarTrend® News Briefs
NeurogesX: The Losing Streak Continues (NGSX)
April 04, 2012
from
Comtex SmarTrend® News Briefs
Neurogesx (NGSX) Files 2.97M Common Shelf for Shareholders
March 29, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7307664 for the full story.
Read More
from
StreetInsider.com News Articles
Hot Stock: NeurogesX, Shares Gain 7.7% (NGSX)
March 15, 2012
from
Comtex SmarTrend® News Briefs
Wedbush Upgrades NeurogesX, Inc. (NGSX) to Outperform; Restructuring Puts NGX-1998 Liquid Formulation On Center Stage
March 14, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7268996 for the full story.
Read More
from
StreetInsider.com News Articles
NeurogesX (NGSX) Tops Q4 EPS by 7c; Announces Restructuring, Cutting 43 Jobs; Received CRL, FDA Seeking Added Data from Qutenza Trials
March 08, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7251935 for the full story.
Read More
from
StreetInsider.com News Articles
NeurogesX (NGSX) Sees Upside Despite Unlikely FDA Approval
March 07, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7249337 for the full story.
Read More
from
StreetInsider.com News Articles
Pre-Open Movers 2/10: (CIE) (ALU) (LNKD) Higher; (AMRS) (GDI) (LF) Lower (more...)
February 10, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7158914 for the full story.
Read More
from
StreetInsider.com News Articles
After-Hours Movers 02/09: (SWIR) (LNKD) (UEPS) Higher; (NGSX) (XIDE) (TRLG) (NUAN) Lower
February 09, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7157571 for the full story.
Read More
from
StreetInsider.com News Articles
Shares of NeurogesX (NGSX) resume trading down 21%
February 09, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7157494 for the full story.
Read More
from
StreetInsider.com News Articles
NeurogesX (NGSX) Confirms FDA Panel Did Not Recommend Approval of Qutenza
February 09, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7157384 for the full story.
Read More
from
StreetInsider.com News Articles
Shares of NeurogesX (NGSX) to resume trading at 5:50pm ET
February 09, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7157382 for the full story.
Read More
from
StreetInsider.com News Articles
FDA Panel Votes 12-0 Against Effectiveness of NeurogesX's (NGSX) Qutenza
February 09, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7155478 for the full story.
Read More
from
StreetInsider.com News Articles
NeurogesX (NGSX) Halted Ahead of FDA Panel Meeting
February 09, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7152832 for the full story.
Read More
from
StreetInsider.com News Articles
Hot Stock: NeurogesX, Shares Drop 10.2% (NGSX)
February 08, 2012
from
Comtex SmarTrend® News Briefs
NeurogesX (Nasdaq: NGSX) Shares Plunge After FDA Staff Says Pain Patch Might Not Work
February 07, 2012
Northwern, WI 2/7/12 ( StreetBeat ) -- NeurogesX Inc. ( Nasdaq: NGSX ) plunged as much as 35 percent after U.S. regulators questioned whether the specialty drugmaker proved its patch relieves pain...
Read More
from
Street Beat: Articles
NeurogesX (Nasdaq: NGSX) Shares Plunge After FDA Staff Says Pain Patch Might Not Work
February 07, 2012
Northwern, WI 2/7/12 ( StreetBeat ) -- NeurogesX Inc. ( Nasdaq: NGSX ) plunged as much as 35 percent after U.S. regulators questioned whether the specialty drugmaker proved its patch relieves pain...
Read More
from
Street Beat: Articles
NeurogesX (Nasdaq: NGSX) Shares Plunge After FDA Staff Says Pain Patch Might Not Work
February 07, 2012
Northwern, WI 2/7/12 ( StreetBeat ) -- NeurogesX Inc. ( Nasdaq: NGSX ) plunged as much as 35 percent after U.S. regulators questioned whether the specialty drugmaker proved its patch relieves pain...
Read More
from
Street Beat: Articles
NeurogesX (Nasdaq: NGSX) Shares Plunge After FDA Staff Says Pain Patch Might Not Work
February 07, 2012
Northwern, WI 2/7/12 ( StreetBeat ) -- NeurogesX Inc. ( Nasdaq: NGSX ) plunged as much as 35 percent after U.S. regulators questioned whether the specialty drugmaker proved its patch relieves pain...
Read More
from
Street Beat: Articles
Greek Discussions Continue, Markets Open Lower
February 07, 2012
Greek officials continued discussions with lenders and European leaders to finalize an agreement to receive additional bailout funds. The markets opened lower with the Dow losing 19 points to 12,825...
Read More
category
Market News
from
MarketMinute.com Market Updates
FDA Concerned with Effectiveness of NeurogesX's (NGSX) Qutenza Patch
February 07, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7142980 for the full story.
Read More
from
StreetInsider.com News Articles
NeurogesX (NGSX) Falls After FDA Briefing Documents
February 07, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7142809 for the full story.
Read More
from
StreetInsider.com News Articles
NeurogesX, Inc. (NGSX) Names Ronald Martell President and Chief Executive Officer
January 03, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7049096 for the full story.
Read More
from
StreetInsider.com News Articles
NeurogesX (NGSX) Reports FDA Committee will Review sNDA for Qutenza 8% Patch
December 15, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7023855 for the full story.
Read More
from
StreetInsider.com News Articles
< Previous
1
2
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
Your browser does not support iframes.